Publisher details
Elsevier/Academic Press
located at :
Amsterdam
Related collections :
|
Available items(s) from this publisher (6)



Antimicrobial Stewardship : Developments in Emerging and Existing infectious Diseases [printed text] / Céline Pulcini, Author ; Onder Ergonul, Author ; Fusun Can, Author . - Amsterdam : Elsevier/Academic Press, 2017 . - 349 p. : ill. ; 22 cm. - (Developments in Emerging and Existing Infectious Diseases; vol. 2) .
ISBN : 978-0-12-810477-4 : 145.59
Languages : English (eng)
Descriptors: Indexation
Anti-Infective Agents ; Drug Resistance, Microbial ; prevention and control
Classification
QV 250 Anti-infective agents. DisinfectantsAbstract: Antimicrobial Stewardship (AMS), Volume Two includes the experience of ESGAP workshops and courses on antibiotic stewardship since 2012. It combines clinical and laboratory information about AMS, with a focus on human medicine.
The ESCMID study group on antibiotic policies (ESGAP) is one of the most productive groups in the field, organizing courses and workshops. This book is an ideal tool for the participants of these workshops.
With short chapters (around 1500 words) written on different topics, the authors insisted on the following points: A hands on, practical approach, tips to increase success, a description of the most common mistakes, a global picture (out- and inpatient settings, all countries) and a short list of 10-20 landmark references.
. Focuses on the most recent antimicrobial stewardship strategies
. Provides a detailed description of laboratory support
. Offers a balanced synthesis of basic and clinical sciences for each individual case, presenting clinical courses of the cases in parallel with the pathogenesis and detailed microbiological information for each infection
. Describes the prevalence and incidence of the global issues and current therapeutic approaches
. Presents the measures for infection controlRecord link: https://kce.docressources.info/index.php?lvl=notice_display&id=4443 Hold
Place a hold on this item
Copies (1)
Barcode Call number Media type Location Section Status 10273-03358 QV 250 / PUL Book KCE Library (10.124) Due for return by 06/23/2019 Readers who borrowed this document also borrowed:
Droit institutionnel de l'Union européenne Blumann, Claude ggplot2 Wickham, Hadley The European Union Kenealy, Daniel
[serial] See available issues Search in serial Clinical immunology and immunopathology = Clin Immunol Immunopathol [printed text] . - Amsterdam : Elsevier/Academic Press, 1972-1998.
ISSN : 0090-1229
IF : none mentioned
SJR : none mentioned
Indexed :
MEDLINE (1973-1998)
Reader accessibility : http://jinfo.lub.lu.se/jinfo?func=fullRecord&jId=287&issn=00901229
Languages : English (eng)
Descriptors: Classification
W 1 Serials. Periodicals
Indexation
Allergy and Immunology ; Peer Review ; Periodicals ; United StatesAbstract: Research Areas Include:
Ageing
Allergy
Autoimmunity
Biotechnology
Clinical Laboratory Immunology
HIV
Immunodermatology
Immunohematology
Immunotoxicology/Environmental
Infection and Immunity
Mucosal Immunity
Neuroimmunology
Primary Immunodeficiency
Transplantation
Tumor Immunology
VaccinesLink for e-copy: http://vdic.idm.oclc.org/login?url=https://www.sciencedirect.com/journal/clinica [...] Format of e-copy: VDIC IP recognition (1995-1998) Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=2208
[serial] See available issues Search in serial Epidemics [printed text] / Neil Ferguson, Editor ; Hans Heesterbeek, Editor . - Amsterdam : Elsevier/Academic Press, 2009.
ISSN : 1755-4365
Languages : English (eng)
Descriptors: Classification
W 1 Serials. Periodicals
Indexation
Disease Transmission, Infectious ; Infectious Disease Transmission, Vertical ; Medical virology ; Open access publishing ; Peer Review ; Periodicals ; Public HealthAbstract: The journal will publish papers on infectious disease dynamics in the broadest sense. Its scope covers both within-host dynamics of infectious agents and dynamics at the population level, particularly the interaction between the two. Areas of emphasis includce: spread, transmission, persistence, implications and population dynamics of infectious diseases; population and public health as well as policy aspects of control and prevention; dynamics at the individual level; interaction with the environment, ecology and evolution of infectious diseases, as well as the population genetics and molecular evolution of infectious agents. The journal will only publish papers that use high quality novel or published data in their analysis. Contents note: IF: http://www.journals.elsevier.com/epidemics
SJR: http://www.scimagojr.com/journalsearch.php?q=17300154924&tip=sid&clean=0
Indexed in:
Index medicus: v1n1, Mar. 2009-
MEDLINE: v1n1, Mar. 2009-
PubMed: v1n1, Mar. 2009-Link for e-copy: http://www.sciencedirect.com/science/journal/17554365 Format of e-copy: PDF [Open Access] Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=3683
Osteoporosis : Volume 1 [printed text] / Robert Marcus, Author ; David Feldman, Author ; Dorothy Nelson, Author ; Clifford J. Rosen, Author . - 3rd Edition . - Amsterdam : Elsevier/Academic Press, 2008 . - 972 p. : ill. ; 27 cm.
ISBN : 978-0-12-370545-7 : 312,95
Now in its third edition, Osteoporosis, is the most comprehensive, authoritative reference on this disease. Written by renowned experts in the field, this two-volume reference is a must-have for academic and medical libraries, physicians, researchers, and any company involved in osteoporosis research and development. Worldwide, 200 million women between 60-80 suffer from osteoporosis and have a lifetime risk of fracture between 30 and 40 percent continuing to make osteoporosis a hot topic in medicine. This newest edition covers everything from basic anatomy and physiology to diagnosis, management and treatment in a field where direct care costs for osteoporitic fractures in the U.S. reach up to $18 billion each year.
Languages : English (eng)
Descriptors: Indexation
Disease ; Economics ; Osteoporosis ; Therapy
Classification
WE 250 OsteoporosisContents note: Introduction -- The Bone Organ System: Form and Function -- The Nature of Osteoporosis -- The Economics of Osteoporosis -- Reflections on Osteoporosis -- Skeletal Heterogeneity and the Purposes of Bone Remodeling: Implications for the -- Understanding of Osteoporosis -- Basic Science/Bone Biology -- Osteoblast Biology -- Osteoclast Biology -- Osteocytes -- The Regulatory Role of Matrix Proteins in Mineralization of Bone -- Development of the Skeleton -- Mouse Genetics as a Tool to Study Bone Development and Physiology -- Parathyroid Hormone and Parathyroid Hormone-Related Protein -- Vitamin D: Biology, Action, and Clinical Implications -- Regulation of Bone Cell Function by Estrogens -- Androgens and Skeletal Biology: Basic Mechanisms -- Phosphatonins -- Wnt Signaling in Bone -- Cytokines and Bone Remodeling -- Skeletal Growth Factors -- Intercellular Communication During Bone Remodeling -- Structural and Biomechanics -- Skeletal Development: Mechanical Consequences of Growth, Aging and Disease -- Inhibition of Osteoporosis by Biophysical Intervention -- Biomechanics of Age-Related Fractures -- Bone Quality -- Epidemiology & Risk Factors -- Epidemiologic Methods in Studies of Osteoporosis -- Race, Ethnicity and Osteoporosis -- The Study of Osteoporotic Fractures (SOF): Major Findings and Contributions -- Bone Mineral Acquisition in Utero and During Infancy and Childhood -- Bone Acquisition in Adolescence -- Genetic Determinants of Osteoporosis -- Nutrition and Risk for Osteoporosis -- Physical Activity in Prevention of Osteoporosis and Associated Fractures -- Premenopausal Reproductive and Hormonal Characteristics and the Risk for Osteoporosis -- Non-Skeletal Risk Factors for Osteoporosis and Fractures -- Falls as Risk Factors for Fracture -- Assessment of Fracture Risk -- Outcomes of Osteoporotic Fractures -- Pathophysiology -- Local and Systemic Factors in the Pathogenesis of Osteoporosis -- Animal Models for Osteoporosis -- Estrogen, Bone Homeostasis and Osteoporosis -- Postmenopausal Osteoporosis: How the Hormonal Changes of Menopause Cause Bone Loss -- Osteoporosis in Men: Epidemiology, Pathophysiology, and Clinical Characterization -- Osteoporosis in Childhood and Adolescence -- Glucocorticoid-Induced Osteoporosis -- Adult Scoliosis, Degenerative Disease, and BMD: a Sub-Segmental Analytic Approach -- Mechanisms of Immobilization-induced Bone Loss -- Leptin-Dependent Regulation of Bone Mass -- Thyroid Hormone and the Skeleton -- Osteoporosis in Gastrointestinal, Pancreatic, and Hepatic Disease -- The Skeletal Actions of Parathyroid Hormone in Primary Hyperparathyroidism and in Osteoporosis -- Osteogenesis Imperfecta and Other Defects of Bone Development as Occasional Causes of Adult Osteoporosis -- Osteoporosis Associated with Illnesses and Medications -- Transplantation Osteoporosis -- Osteoporosis Associated with Cancer Therapy -- Osteoporosis Associated with Pregnancy -- Osteoporosis Associated with Rheumatologic Disease -- Oral Bone Loss and Systemic Osteopenia: Potential Treatment and Risks -- Localized Osteoporosis -- Evaluation and Management -- Evaluation of the Patient with Osteoporosis or at Risk for Osteoporosis -- Who Should be Screened: Who Should be Treated? -- Radiology of Osteoporosis -- Clinical Use of Bone Densitometry -- Biochemical Markers of Bone Turnover in Osteoporosis -- The Conundrum of Compliance and Persistence with Oral Bisphosphonates for Postmenopausal Osteoporosis -- An Orthopedic Perspective of Osteoporosis -- Lessons from Bone Histomorphometry on the Mechanism of Action of Osteoporosis Drugs -- Pharmacology and Therapeutics -- Design Considerations for Clinical Investigations of Osteoporosis -- Regulatory Considerations for the Design and Conduct of Osteoporosis Registration Trials -- Evidence-Based Osteoporosis Care -- The Role of Calcium in the Treatment of Osteoporosis -- Vitamin D and its Metabolites and Analogs in the Management of Osteoporosis -- Estrogen Therapy: Prevention and Treatment of Osteoporosis -- Estrogen Analogues: Selective Estrogen Receptor Modulators (SERMs) and Phytoestrogens -- Bisphosphonates: Pharmacology and Use in the Treatment of Osteoporosis -- Calcitonin in Osteoporosis -- Strontium Therapy for Osteoporosis -- Androgens -- Treatment with PTH Peptides -- Growth Hormone and Insulin-like Growth Factors: Potential Applications and Limitations in the Management of Osteoporosis -- New approaches to Osteoporosis Therapeutics Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=1743 Hold
Place a hold on this item
Copies (1)
Barcode Call number Media type Location Section Status 10273-01751 WE 250/MAR Book KCE Library (10.124) Due for return by 06/30/2018 Readers who borrowed this document also borrowed:
La rigueur du qualitatif De Sardan, Olivier Current challenges in pharmacovigilance Osteoporosis Marcus, Robert Le guide du prisonnier en Belgique Beernaert, Marie-Aude La réforme des systèmes de santé Palier, Bruno Evaluating the impact of implementing evidence-based practice Bick, Debra, Graham, Ian D., Sigma Theta Tau International Practical aspects of signal detection in pharmacovigilance Council for International Organizations of Medical Sciences Les soins de santé en belgique Peers, Jan
Osteoporosis : Volume 2 [printed text] / Robert Marcus, Author ; David Feldman, Author ; Dorothy Nelson, Author ; Clifford J. Rosen, Author . - 3rd Edition . - Amsterdam : Elsevier/Academic Press, 2008 . - 967 p. : ill. ; 27 cm.
ISBN : 978-0-12-370546-4 : 312,95
Now in its third edition, Osteoporosis, is the most comprehensive, authoritative reference on this disease. Written by renowned experts in the field, this two-volume reference is a must-have for academic and medical libraries, physicians, researchers, and any company involved in osteoporosis research and development. Worldwide, 200 million women between 60-80 suffer from osteoporosis and have a lifetime risk of fracture between 30 and 40 percent continuing to make osteoporosis a hot topic in medicine. This newest edition covers everything from basic anatomy and physiology to diagnosis, management and treatment in a field where direct care costs for osteoporitic fractures in the U.S. reach up to $18 billion each year.
Languages : English (eng)
Descriptors: Indexation
Disease ; Economics ; Osteoporosis ; Therapy
Classification
WE 250 OsteoporosisContents note: Introduction -- The Bone Organ System: Form and Function -- The Nature of Osteoporosis -- The Economics of Osteoporosis -- Reflections on Osteoporosis -- Skeletal Heterogeneity and the Purposes of Bone Remodeling: Implications for the -- Understanding of Osteoporosis -- Basic Science/Bone Biology -- Osteoblast Biology -- Osteoclast Biology -- Osteocytes -- The Regulatory Role of Matrix Proteins in Mineralization of Bone -- Development of the Skeleton -- Mouse Genetics as a Tool to Study Bone Development and Physiology -- Parathyroid Hormone and Parathyroid Hormone-Related Protein -- Vitamin D: Biology, Action, and Clinical Implications -- Regulation of Bone Cell Function by Estrogens -- Androgens and Skeletal Biology: Basic Mechanisms -- Phosphatonins -- Wnt Signaling in Bone -- Cytokines and Bone Remodeling -- Skeletal Growth Factors -- Intercellular Communication During Bone Remodeling -- Structural and Biomechanics -- Skeletal Development: Mechanical Consequences of Growth, Aging and Disease -- Inhibition of Osteoporosis by Biophysical Intervention -- Biomechanics of Age-Related Fractures -- Bone Quality -- Epidemiology & Risk Factors -- Epidemiologic Methods in Studies of Osteoporosis -- Race, Ethnicity and Osteoporosis -- The Study of Osteoporotic Fractures (SOF): Major Findings and Contributions -- Bone Mineral Acquisition in Utero and During Infancy and Childhood -- Bone Acquisition in Adolescence -- Genetic Determinants of Osteoporosis -- Nutrition and Risk for Osteoporosis -- Physical Activity in Prevention of Osteoporosis and Associated Fractures -- Premenopausal Reproductive and Hormonal Characteristics and the Risk for Osteoporosis -- Non-Skeletal Risk Factors for Osteoporosis and Fractures -- Falls as Risk Factors for Fracture -- Assessment of Fracture Risk -- Outcomes of Osteoporotic Fractures -- Pathophysiology -- Local and Systemic Factors in the Pathogenesis of Osteoporosis -- Animal Models for Osteoporosis -- Estrogen, Bone Homeostasis and Osteoporosis -- Postmenopausal Osteoporosis: How the Hormonal Changes of Menopause Cause Bone Loss -- Osteoporosis in Men: Epidemiology, Pathophysiology, and Clinical Characterization -- Osteoporosis in Childhood and Adolescence -- Glucocorticoid-Induced Osteoporosis -- Adult Scoliosis, Degenerative Disease, and BMD: a Sub-Segmental Analytic Approach -- Mechanisms of Immobilization-induced Bone Loss -- Leptin-Dependent Regulation of Bone Mass -- Thyroid Hormone and the Skeleton -- Osteoporosis in Gastrointestinal, Pancreatic, and Hepatic Disease -- The Skeletal Actions of Parathyroid Hormone in Primary Hyperparathyroidism and in Osteoporosis -- Osteogenesis Imperfecta and Other Defects of Bone Development as Occasional Causes of Adult Osteoporosis -- Osteoporosis Associated with Illnesses and Medications -- Transplantation Osteoporosis -- Osteoporosis Associated with Cancer Therapy -- Osteoporosis Associated with Pregnancy -- Osteoporosis Associated with Rheumatologic Disease -- Oral Bone Loss and Systemic Osteopenia: Potential Treatment and Risks -- Localized Osteoporosis -- Evaluation and Management -- Evaluation of the Patient with Osteoporosis or at Risk for Osteoporosis -- Who Should be Screened: Who Should be Treated? -- Radiology of Osteoporosis -- Clinical Use of Bone Densitometry -- Biochemical Markers of Bone Turnover in Osteoporosis -- The Conundrum of Compliance and Persistence with Oral Bisphosphonates for Postmenopausal Osteoporosis -- An Orthopedic Perspective of Osteoporosis -- Lessons from Bone Histomorphometry on the Mechanism of Action of Osteoporosis Drugs -- Pharmacology and Therapeutics -- Design Considerations for Clinical Investigations of Osteoporosis -- Regulatory Considerations for the Design and Conduct of Osteoporosis Registration Trials -- Evidence-Based Osteoporosis Care -- The Role of Calcium in the Treatment of Osteoporosis -- Vitamin D and its Metabolites and Analogs in the Management of Osteoporosis -- Estrogen Therapy: Prevention and Treatment of Osteoporosis -- Estrogen Analogues: Selective Estrogen Receptor Modulators (SERMs) and Phytoestrogens -- Bisphosphonates: Pharmacology and Use in the Treatment of Osteoporosis -- Calcitonin in Osteoporosis -- Strontium Therapy for Osteoporosis -- Androgens -- Treatment with PTH Peptides -- Growth Hormone and Insulin-like Growth Factors: Potential Applications and Limitations in the Management of Osteoporosis -- New approaches to Osteoporosis Therapeutics Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=1800 Hold
Place a hold on this item
Copies (1)
Barcode Call number Media type Location Section Status 10273-01752 WE 250/MAR Book KCE Library (10.124) Due for return by 06/30/2018 Readers who borrowed this document also borrowed:
Current challenges in pharmacovigilance Osteoporosis Marcus, Robert Practical aspects of signal detection in pharmacovigilance Council for International Organizations of Medical Sciences Les soins de santé en belgique Peers, Jan Evaluating the impact of implementing evidence-based practice Bick, Debra, Graham, Ian D., Sigma Theta Tau International La rigueur du qualitatif De Sardan, Olivier Le guide du prisonnier en Belgique Beernaert, Marie-Aude La réforme des systèmes de santé Palier, Bruno The methods and materials of demography / Siegel, Jacob S. ; David Swanson / Amsterdam : Elsevier/Academic Press (2004)
Permalink
